Medicines Co. (MDCO) News Nov 20, 2014, 5:36 p.m.

Medicines Co. (MDCO) News Nov 20, 2014, 5:36 p.m.
MarketWatch News on MDCO
Medicines Co. shares fall after FDA panel rejects drug application 10:54 a.m. Feb. 13, 2014 - Russ Britt
FDA reviewing Medicines Co. anti-clotting drug 7:56 a.m. Feb. 12, 2014 - MarketWatch.com
Three biopharma companies poised for product OKs in 2014: analyst 12:51 p.m. Jan. 6, 2014 - Russ Britt
Sam Eisenstadt still bullish on stocks 3:28 p.m. Dec. 27, 2013 - Mark Hulbert
Why I stopped using stop loss orders 7:31 a.m. May 9, 2013 - Michael Sincere
Dow, Nasdaq challenge multiyear highs 12:43 p.m. Feb. 19, 2013 - Michael Ashbaugh
Dow, Nasdaq rattle cage on multi-year highs 11:31 a.m. Feb. 19, 2013 - Michael Ashbaugh
Updates, advisories and surprises 9:01 p.m. July 25, 2012 - MarketWatch
Medicines Co. shares jump 12% on earnings report 11:17 a.m. July 25, 2012 - Val Brickates Kennedy
Corrective bounce, or sustainable upturn? 9:59 a.m. June 6, 2012 - Michael Ashbaugh
Stocks to watch Wednesday: Prestige, Timken, Dell 6:59 a.m. Feb. 22, 2012 - MarketWatch
Friday's biggest gaining and declining stocks 4:25 p.m. Sept. 10, 2010 - MarketWatch
Medicines Co. says patent extension denied 5:29 p.m. March 19, 2010 - Wallace Witkowski
Medicines Co. shares tumble on patent defeat 2:50 p.m. March 19, 2010 - Val Brickates Kennedy
A.P. Pharma, Medicines Co. sink 11:22 a.m. March 19, 2010 - Val Brickates Kennedy
Medicines Co. shares reverse, down 9.7% to $8.40 11:01 a.m. March 19, 2010 - Wallace Witkowski
Wednesday's biggest gaining and declining stocks 4:08 p.m. March 17, 2010 - MarketWatch
Abraxis soars; Molecular Insight falls 12:14 p.m. March 17, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:27 p.m. Feb. 17, 2010 - MarketWatch
Medicines Co. gets wider EU OK for anticoagulant 4:03 a.m. Dec. 1, 2009 - Robert Daniel


Other News on MDCO
The Medicines Company (MDCO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 20, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – CLDX ARIA KND MDCO 6:45 a.m. Nov. 20, 2014 - InvestorPlace.com
Expect More Specialty Pharma Deals 7:41 a.m. Nov. 14, 2014 - Barrons.com
Alnylam Pharmaceuticals Staying Ridiculously Busy 11:25 a.m. Nov. 7, 2014 - Seeking Alpha
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 11:28 a.m. Oct. 29, 2014 - Zacks.com
The Medicines Company (MDCO) Jumps: Stock Gains 16.5% - Tale of the Tape 8:25 a.m. Oct. 29, 2014 - Zacks.com
The Medicines Co.'s Angiomax Gets Favorable Court Ruling - Analyst Blog 5:31 p.m. Oct. 28, 2014 - Zacks.com
Twitter Takes A Tumble As Ability To Innovate Comes Into Question 11:44 a.m. Oct. 28, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – TRNX MDCO ACHN AMGN 6:30 a.m. Oct. 28, 2014 - InvestorPlace.com
The Medicines Co.'s Q3 Earnings Fall Y/Y, Guidance Lowered - Analyst Blog 12:00 p.m. Oct. 27, 2014 - Zacks.com
The Medicines' (MDCO) CEO Clive Meanwell on Q3 2014 Results - Earnings Call Transcript 2:43 p.m. Oct. 22, 2014 - Seeking Alpha
The Medicines (MDCO) Q3 2014 Results - Earnings Call Webcast 7:25 a.m. Oct. 22, 2014 - Seeking Alpha
Actavis Expands Antibiotics Presence With Durata Buy 8:58 a.m. Oct. 6, 2014 - Investors Business Daily
Hottest Healthcare Stocks Now – LCI ANAC HALO IRWD 1:00 p.m. Sept. 10, 2014 - InvestorPlace.com
Regado Slumps on Permanent Termination of Revolixys Study - Analyst Blog 4:20 p.m. Aug. 26, 2014 - Zacks.com
Biggest Movers in Healthcare Stocks Now – LGND PODD MDCO CNMD 12:15 p.m. Aug. 26, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – AVNR PBYI CMN MYGN 1:00 p.m. Aug. 18, 2014 - InvestorPlace.com
Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market? 10:38 a.m. Aug. 14, 2014 - Seeking Alpha
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP 2:54 p.m. Aug. 8, 2014 - Zacks.com
The Medicines Co. Offers Investors 25% Upside 9:48 a.m. Aug. 8, 2014 - Barrons.com

Press Releases on MDCO
The Medicines Company Presents New Phase 1 Data Showing Investigational Agent MDCO-216 Modified Key Lipid Parameters and Was Well-Tolerated in Healthy and Coronary Artery Disease (CAD) Patients 10:30 a.m. Nov. 16, 2014 - BusinessWire - BZX
The Medicines Company to Present New Data on Investigational Lipid-Modifying Agent MDCO-216and Investigational Antiplatelet Agent Cangrelor at 2014 American Heart Association (AHA) Annual Scientific Sessions in Chicago 10:32 a.m. Nov. 14, 2014 - BusinessWire - BZX
The Medicines Company to Participate in Credit Suisse Healthcare Conference 11:07 a.m. Nov. 11, 2014 - BusinessWire - BZX
Health Economic Data on The Medicines Company’s Infectious Disease and Cardiology Portfolios to be Presented at the 17th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 3:00 p.m. Nov. 7, 2014 - BusinessWire - BZX
The Medicines Company Announces First Patient Enrollment in Phase 3 Studies of CARBAVANCE™ in Development for the Treatment of Serious Bacterial Infections Due to Gram-Negative Bacteria 6:30 a.m. Nov. 5, 2014 - BusinessWire - BZX
Update to The Medicines Company Investor & Analyst Day on November 5 4:33 p.m. Nov. 4, 2014 - BusinessWire - BZX
The Medicines Company to Webcast Investor & Analyst Day onNovember 5 4:07 p.m. Oct. 30, 2014 - BusinessWire - BZX
The Medicines Company Announces Presentation of Investigational Hemostatic Agent RAPLIXA™ (fibrin sealant) Phase III FINISH-3 Trial Results at the 2014 Clinical Conference of the American College of Surgeons 11:30 a.m. Oct. 28, 2014 - BusinessWire - BZX
Alnylam and The Medicines Company Announce Filing of a Clinical Trial Application to Initiate a Phase 1 Study for ALN-PCSsc, an Investigational, Subcutaneously Administered RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia 8:05 a.m. Oct. 28, 2014 - BusinessWire - BZX
The Medicines Company Wins Favorable Judgment in Angiomax® (Bivalirudin) Patent Litigation 8:04 p.m. Oct. 27, 2014 - BusinessWire - BZX
The Medicines Company Announces Participation in 2014 American College of Emergency Physicians Scientific Assembly 2:54 p.m. Oct. 24, 2014 - BusinessWire - BZX
Opposing Market Forces Lead to Limited Growth of the Acute Pain Market Through 2023 2:00 p.m. Oct. 23, 2014 - PR Newswire - PRF
The Medicines Company Reports Third Quarter and First Nine Months 2014 Results 7:03 a.m. Oct. 22, 2014 - BusinessWire - BZX
Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 6:34 p.m. Oct. 14, 2014 - PR Newswire - PRF
The Medicines Company to Announce Third Quarter 2014 Financial Results on Wednesday, October 22, 2014 7:20 p.m. Oct. 8, 2014 - BusinessWire - BZX
The Medicines Company Infectious Disease Portfolio Data to Be Presented at ID Week 2014 2:22 p.m. Oct. 6, 2014 - BusinessWire - BZX
The Medicines Company to Webcast Infectious Disease Care Investor & Analyst Day on September 24 7:00 p.m. Sept. 23, 2014 - BusinessWire - BZX
Frazier Healthcare Appoints David Socks as Venture Partner, Establishes Boston Presence 8:00 a.m. Sept. 19, 2014 - BusinessWire - BZX
The Medicines Company to Review ORBACTIVTM (oritavancin) Launch Readiness on Tuesday, September 16, 2014 11:30 a.m. Sept. 12, 2014 - BusinessWire - BZX
The Medicines Company to Present New Data from its Infectious Disease Portfolio at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 1:12 p.m. Aug. 27, 2014 - BusinessWire - BZX